Eledon reports Q3 2026 results, Phase 3 LEGACY trial on track for year-end startNov 12Quarterly updateEledon Pharmaceuticalstegoprubart
Sanofi's Phase 3 vYF yellow fever vaccine trial in children active, not recruitingNov 6Weekly roundup, 4 itemsbelumosudilcetirizine hydrochloride and pseudoephedrine hydrochloride
Boehringer Ingelheim posts Brightline-2 brigimadlin results; BI 4060107 trial recruitsOct 15Weekly roundup, 5 itemsBoehringer Ingelheimempagliflozin
Amgen gets FDA biosimilar supplement approval for RIABNI; posts new evolocumab PK trialOct 2Weekly roundup, 5 itemsAmgenapremilastUpdated
Eledon registers Phase 3 trial comparing tegoprubart with tacrolimus in kidney transplantSep 23Trial updateEledon Pharmaceuticalstacrolimus
Eledon reports Q2 2026 results, confirms Phase 3 kidney transplant trial on track for late 2026Aug 13Quarterly updateEledon Pharmaceuticalstegoprubart